An Oral Interleukin-23-Receptor Antagonist Peptide for Plaque Psoriasis. Bissonnette R, Pinter A, Ferris LK, Gerdes S, et al. N Engl J Med 2024;390:510-521.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Bissonnette R, Pinter A, Ferris LK, Gerdes S, et al. An Oral Interleukin-23-Receptor Antagonist Peptide for Plaque Psoriasis. N Engl J Med 2024;390:510-521.
PMID: 38324484